Impetigo Treatment: Market Insights
Impetigo is an acute bacterial skin infection which mainly affects children and infants. Impetigo is caused due to streptococcus or staphylococcus aureus. Impetigo appears as red scores and bumps blister on face especially around nose and mouth, hands and feet. Impetigo is a global disease affecting approximately 162 million worldwide. Impetigo is a contagious disease which spreads through direct contact with the infected person. Impetigo is easy to treat with topical or oral antibiotics. Impetigo in adults is rare, however, minors are more prone to the disease. The sores are filled with pus which on scratching may spread to other parts of skin. Impetigo is treated with appropriate oral or tropical antibiotics which is directly applied to the sores. Major focus is on product improvement and development of advanced ointments, lotions and pills, which will cure the disease at a faster rate. New medications restrict the reoccurrence of disease and improve the appearance of marks. Humidity and heat coupled with eczema develops the infection. Impetigo are of two types: bullous impetigo involves large blisters and non-bullous impetigo or crusted impetigo. According to the American Academy of Family Physicians, incidence of impetigo in the U.K. accounts to 2.8% in children up to four years and 1.6% among children five to 15 years of age.
Find Out More about the Report Coverage
Impetigo Treatment: Market Dynamics
Impetigo is one of the most common bacterial skin disease which significantly increases the demand of its medication. Increasing incidence of impetigo in infant and children in the recent years is expected to fuel the market growth in the near future. Increase in infant population is expected to drive the market of impetigo treatment in the coming years. Introduction of improved versions of topical and oral antibiotics that are cost-effective are the factors, which drive the overall impetigo treatment market over the forecast period. Risk of side effects of antibiotics treatment of impetigo is the major factor that hinders the growth of the global impetigo treatment market.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Impetigo Treatment Market: Segmentation
The global impetigo treatment market is segmented on basis of route of administration, end user and geography.
|Route of Administration||
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Impetigo Treatment Market: Overview
On the basis of type of route of administration, the topical segment has a large revenue share owing to increase in adoption of topical treatment due to more effective results as compared to oral antibiotics which have limited adverse side effect. Also, oral antibiotics are nowadays gaining popularity as they give quick results in a short time period.
Based on end user, the Hospitals segment contributes a large revenue share among others, owing to increasing incidence of impetigo disease and increase in number of dermatologist in the end-use segment.
Explore Persistence Market Research’s expertise in promulgation of the business !
Impetigo Treatment Market: Region-wise Outlook
North America is expected to capture a large share in the global impetigo treatment market over the forecast period due to presence of large number of manufacturers in the region. Increasing incidence of impetigo infection in North America itself increase the demand for impetigo treatment. Europe is expected to capture second large revenue share in the global impetigo treatment market. However, Asia Pacific is expected to register a fast growth during forecast period and is expected to be a profitable market for new players owing to the growing demand of medication for impetigo treatment.
Impetigo Treatment Market: Key Players
Examples of some of the key players present in the global impetigo treatment market are Medimetriks Pharmaceuticals, Inc., Aqua Pharmaceuticals, Teva Pharmaceutical Industries Ltd, and GlaxoSmithKline plc, among others.
The report covers exhaustive analysis on:
- Impetigo Treatment Market Segments
- Impetigo Treatment Market Dynamics
- Historical Actual Market Size, 2012 - 2016
- Impetigo Treatment Market Size & Forecast 2016 to 2024
- Impetigo Treatment Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Impetigo Treatment Market Drivers and Restraints
Regional analysis includes
- North America
- Latin America
- Asia Pacific Excluding China
- Middle East & Africa
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size Recent industry trends
- Key Competition landscape
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance